[FURL=https://www.industryarc.com/Research/Vasculitis-Treatment-Market-Research-502585]Vasculitis Treatment Market[/FURL] size is forecast to reach $743.2 million by 2025, growing at a CAGR of 5.14% during the forecast period 2020-2025. Vasculitis is a medical condition in which inflammation of the blood vessels occurs. It causes changes in the blood vessel walls, including thickening, weakening, narrowing or scarring. These changes can restrict blood flow, resulting in organ and tissue damage. Some forms of vasculitis improve on their own, while others require medication. Some cases of vasculitis are caused by reactions to medicines. Also, some chronic (long-term) infections, including with hepatitis C or hepatitis B virus, can cause vasculitis. Growing prevalence of chronic diseases owing to unhealthy lifestyle, increasing cases of cardiovascular diseases and more investments in healthcare infrastructure are driving the market growth in recent years. Key Takeaways
North America dominated the Vasculitis Treatment Market in the year 2019 owing to the presence of well-developed healthcare system, growing incidences of chronic diseases among the geriatric population and proactive government initiatives to expedite the research activities related to vasculitis treatment. The Vasculitis Treatment Market scope for different regions will be provided in the final report.
Rising prevalence of blood vessel inflammatory diseases, technological advancement in the diagnostic kits and recent approval by FDA for biologics have helped in significant growth of Vasculitis Treatment Market.
Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market will be provided in the Vasculitis Treatment Market report.
Request for Sample of the Report @ [FURL]https://www.industryarc.com/pdfdownload.php?id=502585[/FURL]
Geography - Segment Analysis
North America dominates the geography segment of Vasculitis Treatment Market with a share of more than 41.3% in 2019, followed by North America. Growing prevalence of large vessel vasculitis among the mainstream population, such as giant cell arteritis and Takayasu arteritis has fuelled the market growth in this region. Presence of well-developed healthcare infrastructure and key market players in this region have further helped in the growth of Vasculitis Treatment Market infrastructure.
Drivers – Vasculitis Treatment Market
Rising prevalence of blood vessel inflammatory diseases
Recent approval by FDA for biologics
Vasculitis Treatment Industry Outlook: Vasculitis Treatment Market top 10 companies are Ablynx, Bristol-Myers Squibb Company, Pfizer Inc., Eli Lilly And Company, Hoffmann-La Roche Ag, Gilead, Glaxosmithkline Plc, Merck Co, Inc, Novartis Ag and Novo Nordisk A/S among others.
About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.